MENU
ARQT
AS OF
Feb 4, 03:15 PM (EDT)
Price
$25.91
Change
-$0.28 (-1.07%)
Capitalization
3.21B
21 days until earnings call
Intraday BUY SELL Signals
+Compare
ARQT
Stock ticker: NASDAQ
AS OF
Feb 4, 03:15 PM (EDT)
Price
$25.91
Change
-$0.28 (-1.07%)
Capitalization
3.21B

ARQT Arcutis Biotherapeutics Forecast, Technical & Fundamental Analysis

Arcutis Biotherapeutics Inc is a medical dermatology company... Show more

ARQT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ARQT with price predictions
Feb 03, 2026

ARQT in upward trend: price may jump up because it broke its lower Bollinger Band on January 12, 2026

ARQT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where ARQT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where ARQT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 03, 2026. You may want to consider a long position or call options on ARQT as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARQT advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

ARQT moved below its 50-day moving average on January 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ARQT crossed bearishly below the 50-day moving average on January 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARQT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ARQT entered a downward trend on January 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARQT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.284) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (10.417) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARQT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ARQT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARQT is expected to report earnings to rise 25.83% to 7 cents per share on February 25

Arcutis Biotherapeutics ARQT Stock Earnings Reports
Q4'25
Est.
$0.08
Q3'25
Beat
by $0.15
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.19
The last earnings report on October 28 showed earnings per share of 5 cents, beating the estimate of -9 cents. With 259.51K shares outstanding, the current market capitalization sits at 3.21B.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of treatments for dermatological diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3027 Townsgate Road
Phone
+1 805 418-5006
Employees
296
Web
https://www.arcutis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMEFX19.320.04
+0.21%
Invesco Small Cap Equity R6
LFVCX28.77-0.04
-0.14%
Lord Abbett Focused Small Cap Value C
ARSZX10.18-0.02
-0.20%
AMG River Road Small-Mid Cap Value Z
CVTCX54.10-0.26
-0.48%
Calamos Growth & Income C
JABCX47.16-0.51
-1.07%
Janus Henderson Balanced C

ARQT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with IDYA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
+2.42%
IDYA - ARQT
46%
Loosely correlated
+0.50%
BEAM - ARQT
45%
Loosely correlated
-0.11%
OCUL - ARQT
44%
Loosely correlated
-6.99%
KRYS - ARQT
44%
Loosely correlated
-0.96%
NUVL - ARQT
43%
Loosely correlated
+2.12%
More